Nachrichten zur McKesson Corp. Aktie

Should You Buy, Hold or Sell MCK Stock Following Robust Q3 Earnings?

McKessons strategic growth in oncology, biopharma and tech drives momentum in 2025. Can MCK overcome its sustaining challenges with robust…

McKesson (MCK) Q3 2025 Earnings Call Transcript

MCK earnings call for the period ending December 31, 2024.…

MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts

McKessons third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower…

McKesson misses third-quarter revenue estimates By Reuters

McKesson misses third-quarter revenue estimates…

McKesson misses third-quarter revenue estimates

Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which…

Heres What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings

While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter…

McKesson (MCK) Q3 Earnings and Revenues Miss Estimates

McKesson (MCK) delivered earnings and revenue surprises of -0.12% and 0.18%, respectively, for the quarter ended December 2024. Do the…

McKesson shares fall as Q3 results miss estimates, guidance raised By Investing.com

McKesson shares fall as Q3 results miss estimates, guidance raised…

McKesson to acquire majority stake in PRISM Vision for $850 million By Investing.com

McKesson to acquire majority stake in PRISM Vision for $850 million…

McKesson (MCK) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, McKesson (MCK) stood at $594.75, denoting a -1.63% change from the preceding…

McKesson: Risks Are Skewed To The Downside

…

MCK Stock Gains 4% in 3 Weeks: Should You Buy, Hold or Sell?

McKessons strategic growth in oncology, biopharma and tech drives momentum in 2025. Will MCK overcome its sustaining challenges with robust…

Aktie von McKesson: Kurs heute nahezu konstant (552,7959 €)

Der Kurs der dem Anteilsschein von McKesson kommt kaum von der Stelle. Der jüngste Kurs betrug 576,45 US-Dollar. Kaum verändert…

Bei der Aktie des Arzneimittelgroßhändlers McKesson kommt es zum Gap-Close - hier entsteht eine antizyklische Chance mit geringem Risiko!

McKesson ist einer der weltweit größten Arzneimittelgroßhändler und kontrolliert etwa 37 % der US-Arzneimittelverkäufe. Großhändler wie McKesson spielen eine wichtige…

3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL)

Gulfport Energy, McKesson and Marvell Technology offer broad exposure to the market improving returns during periods of uncertainty…

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

McKesson, Doximity and Veracyte are included in this Analyst Blog.…

McKesson: Einer der größten Medizinversorger der USA setzt auf Zell- und Gentherapien und vereinfacht die Rezeptabwicklung!

Die Börsen blieben an Thanksgiving geschlossen und wir wollen die Verschnaufpause an den Märkten nutzen, um auch in den abgeschlagenen…

MCK Stock Down Despite Latest Partnership to Boost SCD Treatment

The availability of the FDA-approved drug via McKessons cell and gene therapies business is expected to give patients improved treatment…

McKesson Stock Gains 34.1% YTD: Whats Driving the Rally?

MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.…

5 Stocks That Look Promising Following Broker Rating Upgrades

Investors should monitor stocks like American Airlines, Air Canada, DXC, Dollar General, and McKesson for high returns.…

McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

…

McKesson (MCK) Q2 2025 Earnings Call Transcript

MCK earnings call for the period ending September 30, 2024.…

MCK Stock Gains as Q2 Earnings & Sales Top Estimates, 25 EPS View Up

McKessons second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower…

Do Options Traders Know Something About McKesson (MCK) Stock We Dont?

Investors need to pay close attention to McKesson (MCK) stock based on the movements in the options market lately.…

McKesson: The Correction Is Not Over

…

MCK Stocks Uptrend Likely to Continue After Core Ventures Acquisition

McKessons agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.…

McKesson to Buy Stake in Florida Cancer Chain for $2.49 Billion

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately…

Global Teleradiology Market Analysis and Competitive Landscape Report 2024-2032 Featuring FUJIFILM, Koninklijke Philips, General Electric, Oracle, Siemens, GE HEALTHCARE, and McKesson

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Teleradiology Market Report by Technology Imaging Techniques End Users…

McKesson (MCK) Stock Gains 18% YTD: Whats Driving the Rally?

McKessons (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top…

McKesson (MCK) Q1 2025 Earnings Call Transcript

MCK earnings call for the period ending June 30, 2024.…

McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y

McKessons (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to…

McKesson: Sprungbrett Seitwärtskonsolidierung - Chartanalyse

Paris (www.aktiencheck.de) - McKesson: Sprungbrett Seitwärtskonsolidierung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

McKessons (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

McKesson, Cardinal, Cencora interested in buying private cancer clinics - report

…

McKesson, Cencora and Cardinal Health Circle Florida Cancer Specialists

Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of…

McKesson (MCK) Gains 26% Year to Date: Whats Backing the Rally?

McKessons (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and…

3 Reasons Why You Should Hold McKesson (MCK) Stock for Now

McKessons (MCK) robust Biologics business raises optimism about the stock.…

McKesson: Erholung in der Abwärtsbewegung - Chartanalyse

Paris (www.aktiencheck.de) - McKesson: Erholung in der Abwärtsbewegung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

McKesson: Hochlauf nach Bullenkerze - Chartanalyse

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die Aktie von McKesson (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

dailyAKTIEN: McKesson - Hochlauf nach Bullenkerze

…

McKesson (MCK) Reaches 52-Week High: Whats Aiding the Stock?

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug

The availability of the FDA-approved drug via McKessons (MCK) independent specialty pharmacy is expected to give patients improved treatment options…

McKesson (MCK) Gains 26% YTD: Whats Driving the Rally?

McKessons (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty…

Heres Why You Should Hold McKesson (MCK) in Your Portfolio Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.…

McKesson: Steigend wegen Saisonalität - Chartanalyse

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

McKesson (MCK) Hits 52-Week High: Whats Driving the Stock?

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

McKesson (MCK) Q4 2024 Earnings Call Transcript

MCK earnings call for the period ending March 31, 2024.…

McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y

McKessons (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical…

McKesson (MCK) to Report Q4 Earnings: Whats in the Cards?

McKessons (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

McKesson: Time To Get More Cautious

…